Published multicenter study found higher complete wound closure rates and faster healing with Symphony plus standard of care

AUCKLAND, New Zealand, Oct. 5, 2026 /PRNewswire/ -- Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, today announced positive results from a prospective, multicenter randomized controlled trial (RCT) of...